Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03164616
Title Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca

lung non-small cell carcinoma


Durvalumab + Tremelimumab

Cisplatin + Pemetrexed Disodium

Carboplatin + Pemetrexed Disodium

Cisplatin + Gemcitabine

Carboplatin + Gemcitabine


Carboplatin + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA | DEU

Additional content available in CKB BOOST